Aevi Genomic Medicine, Inc. - Special Call
שיחת ועידה Aevi Genomic Medicine Inc
Aevi Genomic Medicine Inc Conference call or earnings call will be held on 29/11/2018 via an 800 number (toll-free). During the earnings conference call's session Aevi Genomic Medicine Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Aevi Genomic Medicine Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical stage biopharmaceutical company with an emphasis on Genomic Medicine. The National Human Genome Research Institute of the National Institute of Health defines "Genomic Medicine" as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Genomic medicine is currently making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease. Medgenics has partnered with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP) to implement a genomics-medicine driven approach to drug development. CAG's assets include a fully automated biorepository containing specimens from more than 60,000 pediatric patients, and 150,000 relatives.קרא עוד שיחת ועידה